|
|
||||||||
1 Departments of Physiology and 2 Internal Medicine, University of Manitoba, Winnipeg R3E 0W3, Canada
Glucose homeostasis was
examined in male transgenic (Tg) mice that overexpressed the human
insulin-like growth factor (IGF)-binding protein (IGFBP)-3 cDNA, driven
by either the cytomegalovirus (CMV) or the phosphoglycerate
kinase (PGK) promoter. The Tg mice of both lineages
demonstrated increased serum levels of human (h) IGFBP-3 and
total IGF-I compared with wild-type (Wt) mice. Fasting blood glucose
levels were significantly elevated in 8-wk-old CMV-binding protein
(CMVBP)-3- and PGK binding protein (PGKBP)-3-Tg mice compared with Wt
mice: 6.35 ± 0.22 and 5.22 ± 0.39 vs. 3.99 ± 0.26 mmol/l, respectively. Plasma insulin was significantly elevated only in CMVBP-3-Tg mice. The responses to a glucose challenge were
significantly increased in both Tg strains: area under the glucose
curve = 1,824 ± 65 and 1,910 ± 115 vs. 1,590 ± 67 mmol · l
1 · min for CMVBP-3, PGKBP-3,
and Wt mice, respectively. The hypoglycemic effects of insulin and
IGF-I were significantly attenuated in Tg mice compared with Wt mice.
There were no differences in adipose tissue resistin, retinoid X
receptor-
, or peroxisome proliferator-activated receptor-
mRNA
levels between Tg and Wt mice. Uptake of 2-deoxyglucose was reduced in
muscle and adipose tissue from Tg mice compared with Wt mice. These
data demonstrate that overexpression of hIGFBP-3 results in fasting
hyperglycemia, impaired glucose tolerance, and insulin resistance.
insulin resistance; diabetes; resistin; peroxisome
proliferator-activated receptor-
This article has been cited by other articles:
![]() |
K.-W. Lee, L. J. Cobb, V. Paharkova-Vatchkova, B. Liu, J. Milbrandt, and P. Cohen Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3 Carcinogenesis, August 1, 2007; 28(8): 1653 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Muzumdar, X. Ma, S. Fishman, X. Yang, G. Atzmon, P. Vuguin, F. H. Einstein, D. Hwang, P. Cohen, and N. Barzilai Central and Opposing Effects of IGF-I and IGF-Binding Protein-3 on Systemic Insulin Action. Diabetes, October 1, 2006; 55(10): 2788 - 2796. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takaoka, C. E. Smith, M. K. Mashiba, T. Okawa, C. D. Andl, W. S. El-Deiry, and H. Nakagawa EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G404 - G416. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |